Amylyx Pharmaceuticals
AMLX
#7586
Rank
C$0.45 B
Marketcap
$5.27
Share price
3.62%
Change (1 day)
-75.34%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2024 (TTM): C$0.26 Billion

According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is C$0.27 Billion. In 2023 the company made a revenue of C$0.50 Billion an increase over the revenue in the year 2022 that were of C$30.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2024

20222023$0.1B$0.2B$0.3B$0.4B$0.5B$0.6B0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) C$0.26 B-47.92%
2023 C$0.50 B1574.31%
2022 C$30.16 M
2021 N/A